Driving innovation in India’s pharma R&D through cell and gene therapy
Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…
Browsing Category
Biotech
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in…
The centre brings together advanced lab technologies, expert training, and regulatory-ready workflows to help researchers,…
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
ICT Mumbai, ITRI sign EOI to catalyse ₹30 cr for construction of Mumbai Biocluster building
The Mumbai Biocluster is a response to bridging the “valley of death” between early-stage discovery and scalable clinical and…
BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology…
The BD Libertas Wearable Injector is a prefilled, patient ready-to-use drug delivery system designed to enable delivery of complex…
AATec Medical, Northway Biotech partner to develop industrial production process for ATL-105…
Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight: GlobalData
GlobalData reveals that ADCs are expected to emerge as the fastest-growing category of medicines in the innovation pipeline for…
Biological E, Recbio collaborate to produce HPV9 vaccine
Recbio to complete technology transfer while BE will manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024
Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…
Andelyn Biosciences uses AAV curator platform to deliver novel gene therapy for ultra-rare NEDAMSS…
The platform allows for the ability to support the exacting viral vector manufacturing needs of different types of patients
FABA, IIL, and ABF launch finishing school programme in Hyderabad
The month-long programme provides intensive, hands-on training in wet lab facilities, offering real-world experience in…
India’s bio-economy can reach $ 300 bn, potentially doubling its growth from 2024
Indian Bio-Economy Report 2024 by the Association of Biotechnology Led Enterprises (ABLE) highlights India’s current bioeconomy,…
Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer…
Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy…
The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData
Merck Life Science and DPIIT MoU aims to empower biotech startups
Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science explains the goals of the MoU, offering mentorship,…
Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a…
Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…
India’s biopharma industry needs to become a little bit more ambitious
In a free wheeling conversation with Viveka Roychowdhury, Dr Dhananjay Patankar, biopharma consultant, explains why Indian…
Biotech startup Exsure raises Rs 3 Cr in Seed round led by Unicorn India Ventures
Exsure is a biotech startup working to reduce the side effects and toxicity of anti-cancer drugs by its patented exosomal…
GLP-1R gold rush: Emerging biotechs can challenge market leaders, says GlobalData
While mega-cap companies dominate the GLP-1R market and are expected to maintain their stronghold in 2030, three smaller biotechs…